Activation of human brown adipose tissue by a β3-adrenergic receptor agonist

Cell Metabolism

Volumn 21, Issue 1, 2015, Pages 33-38

  Cypess, Aaron M ^a   Weiner, Lauren S ^a   Roberts Toler, Carla ^a   Elía, Elisa Franquet ^a   Kessler, Skyler H ^a   Kahn, Peter A ^b   English, Jeffrey ^a   Chatman, Kelly ^c   Trauger, Sunia A ^c   Doria, Alessandro ^a   Kolodny, Gerald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; FLUORINE 18; MIRABEGRON; ACETANILIDE DERIVATIVE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; FLUORODEOXYGLUCOSE F 18; GLUCOSE; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; BINDING AFFINITY; BROWN ADIPOSE TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; OVERACTIVE BLADDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTING METABOLIC RATE; BASAL METABOLIC RATE; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; OBESITY; TANDEM MASS SPECTROMETRY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

RODENTIA;

ACETANILIDES; ADIPOSE TISSUE, BROWN; ADRENERGIC AGONISTS; BASAL METABOLISM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; OBESITY; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, ADRENERGIC, BETA-3; TANDEM MASS SPECTROMETRY; THIAZOLES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84920627180     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.12.009     Document Type: Article

References (40)

1. J.R. Arch Challenges in β(3)-Adrenoceptor Agonist Drug Development Ther. Adv. Endocrinol. Metab. 2 2011 59 64
2. A. Bartelt, O.T. Bruns, R. Reimer, H. Hohenberg, H. Ittrich, K. Peldschus, M.G. Kaul, U.I. Tromsdorf, H. Weller, and C. Waurisch Brown adipose tissue activity controls triglyceride clearance Nat. Med. 17 2011 200 205
3. A.L. Carey, M.F. Formosa, B. Van Every, D. Bertovic, N. Eikelis, G.W. Lambert, V. Kalff, S.J. Duffy, M.H. Cherk, and B.A. Kingwell Ephedrine activates brown adipose tissue in lean but not obese humans Diabetologia 56 2013 147 155
4. M.A. Cawthorne, M.V. Sennitt, J.R. Arch, and S.A. Smith BRL 35135, a potent and selective atypical beta-adrenoceptor agonist Am. J. Clin. Nutr. 55 Suppl 1992 252S 257S
5. C.R. Chapple, V. Dvorak, P. Radziszewski, P. Van Kerrebroeck, J.J. Wyndaele, B. Bosman, P. Boerrigter, T. Drogendijk, A. Ridder, I. Van Der Putten-Slob, O. Yamaguchi Dragon Investigator Group A phase II dose-ranging study of mirabegron in patients with overactive bladder Int. Urogynecol. J. 24 2013 1447 1458
6. K.Y. Chen, R.J. Brychta, J.D. Linderman, S. Smith, A. Courville, W. Dieckmann, P. Herscovitch, C.M. Millo, A. Remaley, P. Lee, and F.S. Celi Brown fat activation mediates cold-induced thermogenesis in adult humans in response to a mild decrease in ambient temperature J. Clin. Endocrinol. Metab. 98 2013 E1218 E1223
7. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. Palmer, Y.H. Tseng, and A. Doria Identification and importance of brown adipose tissue in adult humans N. Engl. J. Med. 360 2009 1509 1517
8. A.M. Cypess, Y.C. Chen, C. Sze, K. Wang, J. English, O. Chan, A.R. Holman, I. Tal, M.R. Palmer, G.M. Kolodny, and C.R. Kahn Cold but not sympathomimetics activates human brown adipose tissue in vivo Proc. Natl. Acad. Sci. USA 109 2012 10001 10005
9. A.M. Cypess, A.P. White, C. Vernochet, T.J. Schulz, R. Xue, C.A. Sass, T.L. Huang, C. Roberts-Toler, L.S. Weiner, and C. Sze Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat Nat. Med. 19 2013 635 639
10. C.J. de Souza, M.F. Hirshman, and E.S. Horton CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats Diabetes 46 1997 1257 1263
11. FDA (2012a) Advisory Committee Briefing Document Mirabegron (YM178) For the Treatment of Overactive Bladder, April 5, 2012. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298285.pdf accessed 6 November 2014).
12. FDA (2012b) Summary of safety and efficacy as basis for Advisory Committee briefing document for mirabegron, April 5th 2012. Division of Reproductive and Urologic Products, Office of New Drugs Center for Drug Evaluation and Research of Food and Drug Administration. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298284.pdf (accessed 6 November 2014).
13. K.D. Hall, G. Sacks, D. Chandramohan, C.C. Chow, Y.C. Wang, S.L. Gortmaker, and B.A. Swinburn Quantification of the effect of energy imbalance on bodyweight Lancet 378 2011 826 837
14. E. Hondares, R. Iglesias, A. Giralt, F.J. Gonzalez, M. Giralt, T. Mampel, and F. Villarroya Thermogenic activation induces FGF21 expression and release in brown adipose tissue J. Biol. Chem. 286 2011 12983 12990
15. N.Z. Jespersen, T.J. Larsen, L. Peijs, S. Daugaard, P. Homøe, A. Loft, J. de Jong, N. Mathur, B. Cannon, and J. Nedergaard A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans Cell Metab. 17 2013 798 805
16. H. Kim, P.A. Pennisi, O. Gavrilova, S. Pack, W. Jou, J. Setser-Portas, J. East-Palmer, Y. Tang, V.C. Manganiello, and D. Leroith Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice Am. J. Physiol. Endocrinol. Metab. 290 2006 E1227 E1236
17. T.M. Larsen, S. Toubro, M.A. van Baak, K.M. Gottesdiener, P. Larson, W.H. Saris, and A. Astrup Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men Am. J. Clin. Nutr. 76 2002 780 788
18. M.E. Lidell, M.J. Betz, O. Dahlqvist Leinhard, M. Heglind, L. Elander, M. Slawik, T. Mussack, D. Nilsson, T. Romu, and P. Nuutila Evidence for two types of brown adipose tissue in humans Nat. Med. 19 2013 631 634
19. M. Malik, E.M. van Gelderen, J.H. Lee, D.L. Kowalski, M. Yen, R. Goldwater, S.K. Mujais, M.P. Schaddelee, P. de Koning, and A. Kaibara Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study Clin. Pharmacol. Ther. 92 2012 696 706
20. S. Masutani, H.J. Cheng, A. Morimoto, H. Hasegawa, Q.H. Han, W.C. Little, and C.P. Cheng β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure Am. J. Physiol. Heart Circ. Physiol. 305 2013 H923 H930
21. O. Muzik, T.J. Mangner, W.R. Leonard, A. Kumar, J. Janisse, and J.G. Granneman 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat J. Nucl. Med. 54 2013 523 531
22. V. Ouellet, S.M. Labbé, D.P. Blondin, S. Phoenix, B. Guérin, F. Haman, E.E. Turcotte, D. Richard, and A.C. Carpentier Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans J. Clin. Invest. 122 2012 545 552
23. L.M. Redman, L. de Jonge, X. Fang, B. Gamlin, D. Recker, F.L. Greenway, S.R. Smith, and E. Ravussin Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study J. Clin. Endocrinol. Metab. 92 2007 527 531
24. E. Sacco, and R. Bientinesi Mirabegron: a review of recent data and its prospects in the management of overactive bladder Ther. Adv. Urol. 4 2012 315 324
25. H.S. Sacks, J.N. Fain, S.W. Bahouth, S. Ojha, A. Frontini, H. Budge, S. Cinti, and M.E. Symonds Adult epicardial fat exhibits beige features J. Clin. Endocrinol. Metab. 98 2013 E1448 E1455
26. M. Saito, Y. Okamatsu-Ogura, M. Matsushita, K. Watanabe, T. Yoneshiro, J. Nio-Kobayashi, T. Iwanaga, M. Miyagawa, T. Kameya, and K. Nakada High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity Diabetes 58 2009 1526 1531
27. L.Z. Sharp, K. Shinoda, H. Ohno, D.W. Scheel, E. Tomoda, L. Ruiz, H. Hu, L. Wang, Z. Pavlova, V. Gilsanz, and S. Kajimura Human BAT possesses molecular signatures that resemble beige/brite cells PLoS ONE 7 2012 e49452
28. K.I. Stanford, R.J. Middelbeek, K.L. Townsend, D. An, E.B. Nygaard, K.M. Hitchcox, K.R. Markan, K. Nakano, M.F. Hirshman, Y.H. Tseng, and L.J. Goodyear Brown adipose tissue regulates glucose homeostasis and insulin sensitivity J. Clin. Invest. 123 2013 215 223
29. T. Takasu, M. Ukai, S. Sato, T. Matsui, I. Nagase, T. Maruyama, M. Sasamata, K. Miyata, H. Uchida, and O. Yamaguchi Effect of (R)-2-(2-aminothiazol-4-yl)-4′-2-[(2-hydroxy-2-phenylethyl)amino]ethyl acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function J. Pharmacol. Exp. Ther. 321 2007 642 647
30. M.G. Ursino, V. Vasina, E. Raschi, F. Crema, and F. De Ponti The beta3-adrenoceptor as a therapeutic target: current perspectives Pharmacol. Res. 59 2009 221 234
31. A.A. van der Lans, J. Hoeks, B. Brans, G.H. Vijgen, M.G. Visser, M.J. Vosselman, J. Hansen, J.A. Jörgensen, J. Wu, and F.M. Mottaghy Cold acclimation recruits human brown fat and increases nonshivering thermogenesis J. Clin. Invest. 123 2013 3395 3403
32. W.D. van Marken Lichtenbelt, J.W. Vanhommerig, N.M. Smulders, J.M. Drossaerts, G.J. Kemerink, N.D. Bouvy, P. Schrauwen, and G.J. Teule Cold-activated brown adipose tissue in healthy men N. Engl. J. Med. 360 2009 1500 1508
33. S.S. Vansal, and D.R. Feller Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes Biochem. Pharmacol. 58 1999 807 810
34. J. Villarroya, R. Cereijo, and F. Villarroya An endocrine role for brown adipose tissue? Am. J. Physiol. Endocrinol. Metab. 305 2013 E567 E572
35. K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, N.J. Savisto, S. Enerbäck, and P. Nuutila Functional brown adipose tissue in healthy adults N. Engl. J. Med. 360 2009 1518 1525
36. M.J. Vosselman, A.A. van der Lans, B. Brans, R. Wierts, M.A. van Baak, P. Schrauwen, and W.D. van Marken Lichtenbelt Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans Diabetes 61 2012 3106 3113
37. C. Weyer, P.A. Tataranni, S. Snitker, E. Danforth Jr., and E. Ravussin Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans Diabetes 47 1998 1555 1561
38. J. Wu, P. Boström, L.M. Sparks, L. Ye, J.H. Choi, A.H. Giang, M. Khandekar, K.A. Virtanen, P. Nuutila, and G. Schaart Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human Cell 150 2012 366 376
39. T. Yoneshiro, S. Aita, M. Matsushita, T. Kayahara, T. Kameya, Y. Kawai, T. Iwanaga, and M. Saito Recruited brown adipose tissue as an antiobesity agent in humans J. Clin. Invest. 123 2013 3404 3408
40. M.C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini, B. Cannon, J. Nedergaard, and S. Cinti The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue FASEB J. 23 2009 3113 3120